Clover Health Investments, Corp. (CLOV)
USD 3.15
(-1.87%)
USD 3.15
(-1.87%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.03 Billion | 3.47 Billion | 1.47 Billion | 672.88 Million | 462.26 Million | 281.02 Million |
| Cost of Revenue | 1.77 Billion | 3.45 Billion | 1.55 Billion | 590.46 Million | 449.7 Million | - |
| Gross Profit | 257.33 Million | 22.73 Million | -79.18 Million | 82.42 Million | 12.56 Million | 281.02 Million |
| Operating Expenses | 1.98 Billion | 393.65 Million | 557.81 Million | 175.12 Million | 195.76 Million | 475.99 Million |
| Selling, General and Administrative Expenses | 444.72 Million | 486.64 Million | 445.74 Million | 191.7 Million | 187.32 Million | 187.28 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 21.14 Million | -92.98 Million | 112.06 Million | -16.57 Million | 8.43 Million | - |
| Cost and Expenses | 2.24 Billion | 3.84 Billion | 2.1 Billion | 765.59 Million | 645.46 Million | 475.99 Million |
| Operating Income | -208.54 Million | -370.92 Million | -636.99 Million | -92.7 Million | -183.19 Million | -185.79 Million |
| Interest Expense | 7000.00 | 1.36 Million | 16.91 Million | 57.1 Million | 39.06 Million | - |
| Income Tax Expense | - | -33.44 Million | 16.91 Million | 57.1 Million | 39.06 Million | -16.13 Million |
| Earnings before Tax | -213.36 Million | -338.84 Million | -587.75 Million | -91.58 Million | -363.73 Million | -201.92 Million |
| Net Income | -213.36 Million | -305.4 Million | -604.66 Million | -148.69 Million | -402.8 Million | -201.92 Million |
| Earnings Per Share Basic | -0.44 | -0.64 | -1.46 | -1.68 | -3.89 | -4.81 |
| Earnings Per Share Diluted | -0.44 | -0.64 | -1.46 | -1.68 | -3.89 | -4.81 |
| Weighted Average Shares Outstanding | 482.17 Million | 476.24 Million | 412.92 Million | 88.69 Million | 103.5 Million | 42.01 Million |
| Weighted Average Shares Outstanding (Diluted) | 482.17 Million | 476.24 Million | 412.92 Million | 88.69 Million | 103.5 Million | 42.01 Million |
| Gross Margin | 0.13 | 0.01 | -0.05 | 0.12 | 0.03 | 1.00 |
| EBIT Margin | -0.10 | -0.11 | -0.43 | -0.14 | -0.40 | -0.06 |
| Profit Margin | -0.10 | -0.09 | -0.41 | -0.22 | -0.87 | -0.72 |
| EBITDA | -210.84 Million | -337.01 Million | -569.6 Million | -78.72 Million | -182.64 Million | -16.13 Million |
| Earnings Before Tax Margin | -0.10 | -0.11 | -0.43 | -0.14 | -0.40 | -0.66 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 356.24 Million | 346.45 Million | 2.02 Billion | 505.43 Million | 482.06 Million | 513.62 Million |
| Cost of Revenue | 248.34 Million | 265.16 Million | 1.77 Billion | 447.98 Million | 418.95 Million | 436.95 Million |
| Gross Profit | 107.89 Million | 81.29 Million | 252.52 Million | 57.45 Million | 63.1 Million | 76.67 Million |
| Operating Expenses | 100.25 Million | 104.11 Million | 447.23 Million | 110.6 Million | 103.26 Million | 100.73 Million |
| Selling, General and Administrative Expenses | 99.92 Million | 103.79 Million | - | 109.92 Million | 102.31 Million | 104.87 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | -100.25 Million | -104.11 Million | -447.23 Million | -110.6 Million | 421.22 Million | 437.56 Million |
| Cost and Expenses | -348.6 Million | -369.27 Million | -2.21 Billion | -557.9 Million | 522.22 Million | 537.68 Million |
| Operating Income | 7.18 Million | -22.7 Million | -208.54 Million | -65.66 Million | -41.46 Million | -28.8 Million |
| Interest Expense | - | - | 7000.00 | - | - | 7000.00 |
| Income Tax Expense | -45.31 Million | -820 Thousand | -208.54 Million | -65.66 Million | 596.58 Thousand | 7000.00 |
| Earnings before Tax | 7.17 Million | -23.17 Million | -213.36 Million | -70.47 Million | -41.46 Million | -28.81 Million |
| Net Income | 7.4 Million | -19.17 Million | -213.36 Million | -70.47 Million | -41.46 Million | -28.81 Million |
| Earnings Per Share Basic | 0.02 | -0.04 | - | -0.15 | -0.09 | -0.06 |
| Earnings Per Share Diluted | 0.02 | -0.04 | - | -0.15 | -0.09 | -0.06 |
| Weighted Average Shares Outstanding | 487.48 Million | 486.37 Million | 482.17 Million | 481.6 Million | 480.77 Million | 479.16 Million |
| Weighted Average Shares Outstanding (Diluted) | 487.48 Million | 486.37 Million | 482.17 Million | 481.6 Million | 480.77 Million | 479.16 Million |
| Gross Margin | 0.30 | 0.23 | 0.12 | 0.11 | 0.13 | 0.15 |
| EBIT Margin | 0.02 | -0.06 | - | -0.09 | -0.08 | -0.04 |
| Profit Margin | 0.02 | -0.06 | -0.11 | -0.14 | -0.09 | -0.06 |
| EBITDA | 7.99 Million | -21.21 Million | - | -46.98 Million | -39.59 Million | -23.05 Million |
| Earnings Before Tax Margin | 0.02 | -0.07 | -0.10 | -0.13 | -0.09 | -0.06 |
SNI
ARB
WRHLF
AIV
ORTC
18064K